Enerflex (NYSE:EFXT) Cut to Hold at Wall Street Zen
by Renee Jackson · The Cerbat GemWall Street Zen cut shares of Enerflex (NYSE:EFXT – Free Report) from a buy rating to a hold rating in a research note issued to investors on Friday.
Several other brokerages have also recently commented on EFXT. CIBC dropped their target price on Enerflex from $10.00 to $9.25 and set a “neutral” rating on the stock in a report on Friday, May 9th. Royal Bank Of Canada dropped their price target on Enerflex from $14.00 to $12.00 and set an “outperform” rating on the stock in a report on Thursday, April 17th.
Get Our Latest Stock Report on EFXT
Enerflex Price Performance
Shares of NYSE:EFXT opened at $7.82 on Friday. Enerflex has a 12 month low of $4.73 and a 12 month high of $10.61. The stock has a market cap of $961.87 million, a price-to-earnings ratio of 13.25 and a beta of 1.98. The stock’s 50 day moving average price is $7.21 and its 200 day moving average price is $8.16. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.12 and a quick ratio of 0.83.
Enerflex (NYSE:EFXT – Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.12 by $0.07. Enerflex had a return on equity of 5.23% and a net margin of 3.18%. The firm had revenue of $552.00 million for the quarter, compared to analysts’ expectations of $583.59 million. Equities research analysts anticipate that Enerflex will post 0.25 earnings per share for the current fiscal year.
Enerflex Dividend Announcement
The business also recently declared a dividend, which was paid on Tuesday, June 3rd. Shareholders of record on Thursday, May 22nd were issued a $0.0375 dividend. The ex-dividend date was Wednesday, May 21st. This represents a dividend yield of 1.51%. Enerflex’s dividend payout ratio is currently 18.64%.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. Lazard Asset Management LLC bought a new position in shares of Enerflex in the fourth quarter valued at $82,000. Quantbot Technologies LP bought a new position in shares of Enerflex in the fourth quarter valued at $127,000. Bank of New York Mellon Corp acquired a new stake in Enerflex during the 1st quarter valued at $130,000. TD Waterhouse Canada Inc. raised its stake in Enerflex by 8.7% during the 4th quarter. TD Waterhouse Canada Inc. now owns 17,522 shares of the company’s stock valued at $173,000 after purchasing an additional 1,404 shares during the period. Finally, NewEdge Advisors LLC raised its stake in Enerflex by 984.3% during the 1st quarter. NewEdge Advisors LLC now owns 22,791 shares of the company’s stock valued at $176,000 after purchasing an additional 20,689 shares during the period. Institutional investors own 46.47% of the company’s stock.
About Enerflex
Enerflex Ltd. offers energy infrastructure and energy transition solutions to natural gas markets in North America, Latin America, and the Eastern Hemisphere. The company provides natural gas compression infrastructure, processing, and treated water infrastructure under contract to oil and natural gas customers; power generation rental solutions; custom and standard compression packages for reciprocating and screw compressor applications; re-engineering, re-configuration, and re-packaging of compressors for various field applications; integrated turnkey power generation, gas compression, processing facilities, natural gas compression, processing, and electric power solutions; after-market mechanical services and parts distribution, as well as maintenance solutions to the oil and natural gas industry, operations, and overhaul services; and equipment supply, parts supply, and general asset management.
Further Reading
- Five stocks we like better than Enerflex
- The How And Why of Investing in Oil Stocks
- AutoNation: Growth Engines Make It an Undervalued Stock
- What is Short Interest? How to Use It
- Snowflake Hits 52-Week High—Options Traders Bet on Further Rally
- How to Calculate Return on Investment (ROI)
- 3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking